Replies to post #443976 on Zeev's Turnips Patch-No Politics (ZEEV)

[Zeev Hed]

And once again, I should have stuck with GILD's original bid at $52, now available.

[madrose1]

GILD initiated with an Outperform, valuation range $63-$68@WCHV

The firm is positive on Truvada, a front-line HIV therapeutic, and collaboration with BMS to develop Truvada/Sustiva combination.